[go: up one dir, main page]

GB2181647A - Compositions based on lysine and arginine salts - Google Patents

Compositions based on lysine and arginine salts Download PDF

Info

Publication number
GB2181647A
GB2181647A GB08623076A GB8623076A GB2181647A GB 2181647 A GB2181647 A GB 2181647A GB 08623076 A GB08623076 A GB 08623076A GB 8623076 A GB8623076 A GB 8623076A GB 2181647 A GB2181647 A GB 2181647A
Authority
GB
United Kingdom
Prior art keywords
lysine
arginine
oleate
test
bht
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08623076A
Other versions
GB2181647B (en
GB8623076D0 (en
Inventor
Jean Morelle
Eliane Lauzanne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB8623076D0 publication Critical patent/GB8623076D0/en
Publication of GB2181647A publication Critical patent/GB2181647A/en
Application granted granted Critical
Publication of GB2181647B publication Critical patent/GB2181647B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)

Abstract

Compositions for cosmetic, dermatological and/or alimentary use comprise salts resulting from the association of fatty acids with lysine or arginine of formula: <IMAGE> where R is a hydrocarbon radical straight or branched, saturated or mono-unsaturated comprising from 4 to 30 carbon atoms; and R' is -CH2- for lysine or <IMAGE> for arginine.

Description

SPECIFICATION Compositions based on lysine and arginine The invention relates to new compositions based on salts of lysine and of arginine, in which these basic amino acids are associated with fatty acids. Such associations have antioxidant, emulsifying and antiirritant properties, and can be used in cosmetic, dermatological, and even alimentary compositions, by reason of their biological nature and as they provide protection againsttheformation of pipoperoxides.
These compounds or associations correspond to thefollowing general formula:
in which R represents a hydrocarbon radical, straight or branched, saturated or mon-unsaturated comprising from 4to 30 carbon atoms, R' represents -CH2-for lysine or the guanidyl residue -C-NH-for arginine.
{ NH Experience has shown thatthe use of polyunsaturated fatty acids leads to compositions which are badly tolerated on the skin surface.
These amino acid-fatty acid compounds can be produced by neutralization of the fatty acid with the basic amino acid, in such mannerthata hydroalcoho licsolutioncontaining 10% of one of the compounds shows a pH between 6.5 and 7.5. By way of example, one molecule of oleic acid (about 282 g) is dissolved in 500 to 750 ml of ethanol on a water bath at 50 C with agitation. One molecule of one ofthe amino acids is added slowly, (about 146 g for lysine or 174 g for agrinine). At a temperature not exceeding 55 C, in orderto avoid discolouration, and under reduced pressure, the alcohol and eventually the water is eliminated from the lysine base. In the case of unsaturated fatty acids like oleic or linoleic acids, gels of variable consistency are obtained.Saturated acids yield a solid mass, which can be ground and reduced to powder, and which is of colourvarying between white and beige.
The following Table gives the yields of fatty acids-amino acids, both theoretical and found, as well as the contents of total nitrogen, which determine the degree of purity ofthe product. The mono-unsaturated fatty acid derivatives give with water, in the cold, gels which liquefy on heating. They are soluble in ethanol pure and hydrated, in propylene glycol, and chloroform, but insoluble in acetone, and ethyl acetate. The saturated fatty acid derivatives take the form of powder, and are soluble, after heating, in propyleneglycol, and in glycerol. Theyform gels with water.They are partly soluble in chloroform and sparingly soluble in fats, like stearine, polyox yethylenefatty alcohols, and cetyl alcohol.
Calculated on the anhydrous products Fatty Theoretical mood Acid No. Fatty Amino Nitrogen Fatty Amino Mitrogen Acid Acid Acid Acid Derivates of Lyslne Stearic I 431| 65-8%| 34.2% 421 6.511 66.4k1 33.6% 6.3+ Palmitic 402 63.7%| 36.3% 6,9 % 6.9 64.8% 35.2% 6.72 Oleic 1 428 68.% 24,2% 6.5 % 66-8% 33.2% 6.4 Derivatives of Arginine Stearic 488 62.0% 62.0% 38.0% 12.22% 62.8% 62.8% 37.2%t 11.8% Oleic 486 456| 61.8% 38,2% 12,28% 61.2% 2.8% 12.2%
Identification a) Melting Points (Maquenne Block) Lysine oleate 150 +5 Arginine oleate 170 +5 Lysine palmitate 185 Arginine palmitate 135 Lysinestearate 190 " Argininestearate 170" Lysine myristate 189 " b) Colour Reactions 1 - Into 2 ml of a hydroalcoholic solution, some drops of a ninhydrin solution are poured. The solution is held for some minutes on a boiling water bath. In all cases, there is obtained a brown violet colour.
2-Into 2 ml of a hydroalcoholicsolution, some drops of a sulphuric solution of paradimethylbenzaldehyde are poured. Awhite precipitate is produced.
The mixture is held over a water bath for some minutes, the precipitate disappears, and the solution take on a rose colour.
c) Examination by chromatographic plate For characterization by yield of amino acid, there is usedthefollowing migration solvent: chloroform-methanol-ammonia: 20/20/10.
Migration period: about 30 minuts development: ninhydrin solution, methyl red of bromocresol purple.
Rf Rf Lysine 0.35 Arginine 0.38 Lysine oleate 0.24 Arginine oleate 0.33 Lysine palmitate 0.23 Arginine palmitate 0.33 Lysinestearate 0.23 Argininestearate 0.33 Caprylate 0.23 For characterization by yield of fatty acid, there is used the following migration solvent: petroleum etherdiethylether: 50/50.
Developer: 2-7 dichlorofluorescein or methyl red.
After spraying with a solution of methyl red, the plate iswarmedandexposedwith ammoniavapour.The fatty acids and their amino acid derivatives remain red, while the exposed end of the plate becomes yellow. With the dichlorofluorescein, the plate is exposed to U.V. at 366 nm.
Rf Rf Oleicacid 0.88 Arginineoleate 0.71 Stearic acid 0.66 Argininepalmitate 0.61 Palmitic acid 0.63 Arginine stearate 0.52 Lysine palmitate 0.61 Lysineoleate 0.72 Lysine stearate 0.55 d) Dosages By acidification with hydrochloric acid of a solution of one ofthe derivatives given below, the fatty acid is easily separatedfrom the amino acid. The fatty acid becomes supernatant, whilethe amino acid remains in the water phase in the form of hydrochloride. For the fatty acid, it is sufficientto determine the acidity index to know its identity. Forthatthe amino acid, a test for nitrogen can be effected on the solution, or formaldehyde filtration may be effected.
These fatty acid-amino acid associations ofthe invention can be used alone as emulsifying and emollient agents, or in association with other emui- sifying agents, ionic ornon-ionic according to the final properties desired. Such substances can advan tageously be incorporated in compositions intended to be applied to the skin to remedy a deficiency in lipids as in water. They lead to a particularly oily touch without the inconvenience of a "greasy" character.
The principle other interest of these substances is their antioxidant property. Peroxides have a toxic characterwhich is not negligible, and the free radicals ofwhich are formed (peroxides and hydroperoxides) are not physiologically acceptable. Several authors have shown that it is wrong to attribute to peroxidation and radical oxidation in vivo an important part in the determination ofthe process of aging (HAR MANN d-Free radicaltheoryofaging-J. Geront.
1968/23/476. Prolongation of life, Role ofthefree radical reaction in aging -J. Amer, Geront, Soc.
1969-17-721. HOCHSCHILD R-Lysosomes mem branes and aging Exp. Geront. 1971-6-153. TAPPELA L-Free radical lipid peroxydation damm and its inhibition by vitamin E and selenium - Fed. Proc.
1965-24-73). Ultraviolet radiation leads to theformation of peroxides (SHERVIN E Oxidation and antioxidants in fats and oil processing -J.A.O.C.S.
1978-55-809-VIGNERON M,Autoxidation. Mea suresforprevention 1956-Companyfor Pharmaceutical and Scientific Editions, Paris).These are factors in the aging ofthe skin, showing themselves by a loss of elasticity with the formation of wrinkles.
Protection against peroxidation is of interest, above all in summer because ofthe relatively high intensity of natural ionizing radiation.
Fatty acids like oleic acid are sensitive to autooxidation when not protected, and become antioxidants when they are associated with amino acids.
This is a particularly interesting property according to the invention.
The determination ofthe antioxidant properties of the lipid derivatives of lysine and of arginine has been the subject of numerous treatments of peroxide, after bubbling with air and with oxygen, and principally afterexposureto ultraviolet radiation. Measurements have been carried out on emulsions made with fatty acid-amino acid associations only, as the preparation of cosmetic compositions concerns above all emulsions. Comparative emulsions have been tested which do not contain test substances, but comprise only a polyoxythylenefatty alcohol inthe presence of oil. Multiple oils, as well as oils emulsified with fatty acid-amino acid associations have been tested. The comaprisons have been made with common antiox idant agents: butyl-hydroxytoluene (BHT) or butyl hydroxy anisole (BHA). Oxidation ofthe oils was by bubbling airfor one hourat 50"C, in the presence of 2% and of 4% of lysine oleate, in comparison to an oil not treated but heated and an oil containing 0.1 % of BHT: a) after bubbling; b) after6days; and c) after21 days.
TABLE 1
Content Neutral BHT Oils tested Time of Air Oleate test test after oleate treatment Sesame a) 2% 1.9 1.0 1.5 1.3 b) " 4.9 3.4 4.3 3.6 Carnation a) " 2.4 2.2 1.5 1.4 b) " 4.9 5.7 5.9 5.4 Sunflower a) " 1.4 3.5 1.6 0.4 b) " 3.8 3.5 3.3 3.2 Sweetalmond a) " 5.4 2.1 5.1 1.2 c) " 21.1 6.5 20.6 4.0 Soya a) " 15.0 8.4 17.4 18.1 c) " 29.4 20.4 31.3 27.1 Maize a) " 21.5 22.3 32.0 35.2 c) " 59.4 45.0 61.1 60.2 Peanut a) " 0.8 0.8 0.4 1.1 Olive a) " 2.9 3.8 1.8 1.3 Sweetalmond a) 4% 5.4 0.9 5.1 1.1 Olive a) " 2.9 1.2 1.8 1.3 The figures correspond to the numberofml of sodium hyposu Ifite N/200 per 1 g of oil.
Oxidation of oil by bubbling of oxygen during one hourat50eC. Measurements carried out immediately after treatm ent - Neutra i test without passage of 02.
Oxidation of oils. under U.V. at 50 --A)for 8 hours -B)for 12 hours. Comparison of protection between 2% lysine oleate and 0.1% BHT.
TABLE 2
Oleate Neutral BHT Test Oils Content Oxygen Oleate Test Test Carnation 2% 3.6 2.2 1.9 2.1 Hazelnut " 11.7 1.5 12.4 11.6 Second test " 11.7 1.4 12.3 11.7 Sesame " 1.4 1.2 lA 0.9 Oleicacid " 17.7 10.2 10.6 10.4 Sunflower 14.6 12.6 6.7 13.2 Peanut " 1.5 0.5 1.0 0.8 ; Glycerol Trioleate Sweet almond " 2.7 2.5 0.1 1.7 Sweet almond 4% 2.7 1.1 0.1 1.7 TABLE 3
Tested Oils Period of Test Oleate BHT Exposure Sunflower A 10.5 2.8 5.2 Peanut " 1.7 2.5 4.5 Carnation " 16.0 0.6 11.0 Maize " 9.7 0.7 7.6 Soya " 5.2 0.4 7.5 SweetAlmond" 7.1 1.7 3.8 Sesame " 3.8 0.7 2.2 Glycerol Trioleate Peanut B 4.1 1.4 3.2 Sesame " 10.3 3.2 6.2 Hazelnut " 16.5 2.1 5.8 SweetAlmond " 7.1 4.2 3.8 2% oleate SweetAlmond " " 7.1 1.8 3.8 4% oleate Oxidation of oils under U.V. for 10 hours Comparison of protection between 4% lysine stearate and 0.1 BHT.
TABLE 4
Oils tested Test Stearate BHT Sunflower 12.5 3.0 8.0 Carnation 13.2 0.5 8.5 Maize 10.7 0.6 3.5 Comparison of the antioxidant properties between 0.1% BHT, lysine oleate, and 5% lysine stearate, in the form of emulsion. Test: 5% test oil, 5% polyoxyethylene fatty acid 0.1% BHTintestoil-5% oleateand stearate, 5% test oil.
TABLE 5
Oils tested Test BHT Oleate Stearate Carnation 9.5 2.3 3.4 1.4 Sesame 22.5 3.7 4.4 1.4 SweetAlmond 12.0 2.0 2.1 0.6 Soya 11.4 4.2 4.6 2.3 Comparison of the antioxidant properties of different derivatives of lysine and ofarginine with BHT in different emulsified oils.
Test: polyoxyethylene alcohol 5% -5% oil -90% water BHT: 0.1 % in test emulsion Amino acid derivatives: 5% - 5% oil - 90% water Exposure U.V.:12 hours at 50 .
TABLE 6
Amino acid Oils Tested BHT Test Derivatives Lysine oleate Carnation 2.2 9.5 3.4 Sesame 3.7 22.1 4.4 Olive 2.2 8.4 2.0 SweetAlmond 2.0 12.0 2.1 Soya 4.0 11.5 4.6 Sunflower 2.8 36.0 1.5 Lysine Stearate Sesame 2.0 7.5 1.4 Carnation 1.4 2.2 1.4 Soya 3.0 15.5 2.3 Sweet Almond 1.5 7.6 0.7 Sunflower 2.8 36.0 4.1 Olive 2.2 8.4 1.5 Lysine Palmitate Sweet Almond 2.2 4.5 2.2 Sunflower 1.5 8.1 1.6 Arginine Oleate Sweet Almond 2.3 4.5 2.4 Sunflower 1.5 8.1 1.6 Arginine Palmitate Sweet Almond 2.3 4.5 2.1 Sunflower 1.5 - 8.1 1.3 Arginine Stereate Sweet Almond 2.3 4.7 1.8 Sunflower 1.5 9 1.2 Comparison ofthe antioxidant properties of different associations, fattyacid-amino acid with BHT, accordingto their introduction into the oily phase or the aqueous phase of an emulsion. Exposure to U.V.
18 hours at 22 . Emulsion, according toTable 6aqueous phase: (1)--oily phase (2). BHT is introduced only into the oily phase.
TABLE 7
Test oils in emulsion Amino acid derivatives Olive Sunflower Sweet Almond BHT 5 3.1 4 Test: fatty alcohol 13.5 13.1 10.2 +oil Lysine oleate (1) 5.7 4.7 2.0 (2) 3.2 3.4 1.7 Lysine stearate(1) 4.1 4.6 7.8 (2) 1.7 1.2 3.0 Lysinepalmitate(1) 1.6 4.4 4.8 (2) 1 0.8 3.2 Lysine myristate (1) 2.8 5.0 4.7 1.7 3.7 2.2 Arginineoleate(1) 4.4 5.2 5.5 (2) 3.5 2.6 3.2 Lysine caprylate (1) 4.5 6.0 5.8 2.7 4.4 3.8 The fatty acid-amino acid associations cannot be put in parallel with classical chemical antioxidants, which are used in a weak dose, such as BHT and BHA for example. These associations are not properly called antioxidants; they are principally emulsifying agents, with interesting emollient properties, char acterised by antioxidant properties, which avoid having to use chemical antioxidants.
In the light of numerous determinations of indices of peroxide, shown in the Tables, the following results are put in evidence: 1-By bubbling air or oxygen for one hourat 50 , lysine oleate is observed to lead to an antioxidant protection near or attimes superiorto that of BHT, according to the nature ofthe test oils (Tables 1 and 2).
2-By exposure to ultraviolet radiation during a period between 8 and eighteen hours, both the oleate and the stearate of lysine are effective antioxidants (Tables 3 and 4).
3-In the case of emulsions comprising different oils, exposed to U.V. during 18 hours, lysine stearate leads to results superiorto those obtained with the oleate (Table 5).
4-All the saturated fatty acid or mono-unsaturated fatty acid associations with lysine or arginine are endowed with antiperoxidant properties.
5-The antioxidant protection is higher when the amino acid derivatives are introduced into the oily phase of an emulsion, than in the aqueous phase.
By reason ofthe important of protection against ultraviolet radiation, it will be particularly advantageous to use this kind of substance, of strictly biological character the same as fatty acids and as freeorcombined lysineorarginine,which are normallyfound in tissue, and in particular at the level of the corneal layer, which allows themselves to opposethe disturbing action of solar radiation, relativetothe activity of peroxides.
Use of associations of faffy acids--lysine orarginine Given on the one hand, as has been stated, that there is interest in introducing these associations into fats to protect against auto-oxidation, but on the other hand the fact of high melting points, it is difficult to obtain a homogeneous and limpid mixture, without causing modification ofthe colour ofthe fat, it is preferableto solubilize them in polya Icohols like propyleneglycol or glycerol for example and to introduce this mixture into the fat. Thus there is obtained a limpid mass which, on addition of water, leads to the desired emulsion. Emulsions are then obtained of which the pH is about 7 and which are characterised by a remarkable emollient action.
Byway of non-limiting examples, there are cited as emulsion compositions: 1) Lysineoleate 5 Propyleneglycol 10 Cetyl .................................... alcohol 5 Stearine ...... ... ... 10 Water 100 Preservative qs 2) Lysinestearate 5 5 Propyleneglycol ............................... 10 Stearine 10 Polyoxyethylene fatty alcohol 5 Sweetalmondoil 5 Water 100 Preservative qs 3) Arginineoleate ................................. 5 Glycerol ........................................ 10 Sunflower 10 Polyoxyethylenecetylalcohol 10 Stearine .......... ............. ............ 8 Lipoaminoacid 3 Waterqs 100 Preservative qs One can use, equally, advantageously these associations in hygiene products, such as soaps, shampoos by reason of their emollient and very slippery properties. It will be the same for the preparation of permanent waving solutions in which this kind of association will permit an increase in activity of reducing components, by virtue oftheirtensioactivity, on the one hand and on the other hand by reason ofthe biological nature ofthis kind of substance.
As non-limiting examples, there is mentioned: 1) Toilet soap Cocoa-pa Imistic soap 95 Lysineoleate 5 Coconut oil ................................ soap 95 Lysinestearate 5 2) Shampoos Sodium laurylsulphate 30 Lysineoleate 5 Water ........................................ 65 Etherlaurylsulphate 20 Sodium laurylcollagenate ................. 10 Lysineoleate 5 Water ........................................ 65 3) Permanent waving lotion Ammoniumthiolactate 15 15 Lysineoleate 2 Ammonia ........................................ 70 Water ............... ....... . 73

Claims (7)

1. Compositionsforcosmetic, dermatological andlor alimentary use which comprise salts resulting from the association of fatty acids with Iysine or arginine, corresponding to the following general formula:
in which R represents a hydrocarbon radical straight or branched, saturated or mono-unsaturated comprising from 4to 30 carbon atoms; and R' represents -CH2-for lysine ora guanidyi residue -C-NH-forarginine.
# NH
2. Cosmeticand/ordermatological compositions according to claim 1 in combination with other emulsifiers.
3. Cosmetic, dermatological and/or alimentary compositions according to claim 1 substantially as herein described.
4. A process of producing a composition according to claim 1 which comprises neutralization ofthe fatty acid with the basic amino acid.
5. A process according to claim 4 which is performed in a hydroalcoholic solution at a pH between
6.5 and
7.5.
GB8623076A 1985-10-01 1986-09-25 Compositions based on lysine and arginine salts. Expired GB2181647B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8514536A FR2587900B1 (en) 1985-10-01 1985-10-01 BASIC FATTY-AMINO ACID ASSOCIATIONS WITH EMOLLIENT, EMULSIFIING AND ANTIOXIDANT PROPERTIES FOR COSMETICS, DERMATOLOGY AND FOOD

Publications (3)

Publication Number Publication Date
GB8623076D0 GB8623076D0 (en) 1986-10-29
GB2181647A true GB2181647A (en) 1987-04-29
GB2181647B GB2181647B (en) 1989-10-11

Family

ID=9323421

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8623076A Expired GB2181647B (en) 1985-10-01 1986-09-25 Compositions based on lysine and arginine salts.

Country Status (4)

Country Link
JP (1) JPS6289646A (en)
DE (1) DE3633453A1 (en)
FR (1) FR2587900B1 (en)
GB (1) GB2181647B (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209120A (en) * 1987-08-28 1989-05-04 Hoerrmann Wilhelm Anti-tumour compositions containing lysine derivatives
FR2628419A1 (en) * 1988-03-09 1989-09-15 Biorex Kft NOVEL ANTIVIRAL SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND PROCESS FOR THEIR PREPARATION
GB2226759A (en) * 1987-12-30 1990-07-11 Wilhelm Hoerrmann Pharmaceutical compositions containing lysine
FR2673373A1 (en) * 1991-03-01 1992-09-04 Bague Jean Claude COMPOSITIONS FOR MAKEUP COMPRISING FATTY ACID-BASIC AMINO ACID ASSOCIATIONS FOR FIXING WATER-SOLUBLE COLORING MATERIALS TO THE SKIN.
FR2747309A1 (en) * 1996-04-16 1997-10-17 Morelle Jean Compositions for treating burns and wounds with antimicrobial, anti-free radical and regenerating activity
WO2008006721A1 (en) * 2006-07-14 2008-01-17 Unilever Plc Hair care composition
US20110240050A1 (en) * 2010-04-01 2011-10-06 L'oreal S.A. Cosmetic compositions containing a fatty acid, arginine, and a co-emulsifier
ITMI20111617A1 (en) * 2011-09-08 2013-03-09 Euro Kemical S R L COSMETIC COMPOSITION BASED ON BABASSU OIL
US8440172B2 (en) 2007-07-09 2013-05-14 Symrise Ag Stable soluble salts of phenylbenzimidazole sulfonic acid at PHS at or below 7.0
US20220312803A1 (en) * 2021-03-30 2022-10-06 Apeel Technology, Inc. Edible barrier film composition

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2609998B1 (en) * 1987-01-26 1994-04-15 Morelle Jean NOVEL ANTIOXIDANT SUBSTANCES DERIVED FROM AMINO ACIDS
JP2525214B2 (en) * 1987-12-25 1996-08-14 チッソ株式会社 Ferroelectric liquid crystal composition
WO1992006667A1 (en) * 1990-10-19 1992-04-30 Shiseido Company, Ltd. External preparation for skin
DE4341001A1 (en) * 1993-12-02 1995-06-08 Beiersdorf Ag Topical preparations containing L-arginine
DE19713776A1 (en) * 1997-04-03 1998-10-08 Beiersdorf Ag Light protection preparations with a content of basic amino acids and water-soluble UV filter substances
FR2908300B1 (en) * 2006-11-10 2012-08-24 Oreal COSMETIC COMPOSITION COMPRISING C16-C-30 FATTY ACID AND BASIC ACID, METHODS AND USES.
EP1920760A1 (en) * 2006-11-10 2008-05-14 L'Oréal Cosmetic composition comprising a compound chosen from amino acid salts and derivatives
DE102009034771B4 (en) 2009-07-25 2011-09-01 Martin Schmitt Skin protectant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069659A1 (en) * 1981-07-03 1983-01-12 CHANY, Charles Medicine containing the reaction product of a carboxylic acid and a basic amino acid
EP0078785A1 (en) * 1981-11-04 1983-05-11 "PHARLYSE", Société Anonyme Salts of valproic acid, their preparation and their use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945049A (en) * 1959-05-25 1960-07-12 Gen Mills Inc Salts of basic amino acids and linoleic acid
LU54223A1 (en) * 1967-08-01 1969-03-24
FR1583104A (en) * 1968-08-02 1969-10-17
FR2104992A1 (en) * 1970-09-09 1972-04-28 Melle Bezons Recovering organic arginine salts - by discharging a spray of soln into hot air current
JPS537492B2 (en) * 1973-02-12 1978-03-18
JPS5738640B2 (en) * 1974-02-05 1982-08-17
JPS52156787A (en) * 1976-06-23 1977-12-27 Shiseido Co Ltd Oil-in-water type emulsified composition
US4400295A (en) * 1979-03-24 1983-08-23 Loire Cosmetics Co., Ltd. Emulsifier composition
JPS5653196A (en) * 1979-10-08 1981-05-12 Mitsui Toatsu Chemicals Surfactant composition
JPS5670098A (en) * 1979-11-14 1981-06-11 Mitsui Toatsu Chemicals Surfactant composition
JPS56103104A (en) * 1980-01-19 1981-08-18 Shiseido Co Ltd O/w type emulsion compositon
JPS57125298A (en) * 1981-01-27 1982-08-04 Mitsui Toatsu Chemicals Amino acid-added fatty acid type surfactant composition
EP0126348A2 (en) * 1983-05-19 1984-11-28 Kyoto Pharmaceutical Industries, Ltd. Composition for rectal administration and method of promoting rectal drug absorption

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069659A1 (en) * 1981-07-03 1983-01-12 CHANY, Charles Medicine containing the reaction product of a carboxylic acid and a basic amino acid
EP0078785A1 (en) * 1981-11-04 1983-05-11 "PHARLYSE", Société Anonyme Salts of valproic acid, their preparation and their use

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209120A (en) * 1987-08-28 1989-05-04 Hoerrmann Wilhelm Anti-tumour compositions containing lysine derivatives
GB2209120B (en) * 1987-08-28 1992-01-15 Hoerrmann Wilhelm Drugs containing lysine or hydroxylysine derivatives
GB2226759A (en) * 1987-12-30 1990-07-11 Wilhelm Hoerrmann Pharmaceutical compositions containing lysine
FR2628419A1 (en) * 1988-03-09 1989-09-15 Biorex Kft NOVEL ANTIVIRAL SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND PROCESS FOR THEIR PREPARATION
GB2216522A (en) * 1988-03-09 1989-10-11 Biorex Kft Aminoacid salts of long chain unsaturated carboxylic acids
GB2216522B (en) * 1988-03-09 1992-01-02 Biorex Kft Amino acid salts of long chain unsaturated fatty acid
BE1003663A3 (en) * 1988-03-09 1992-05-19 Biorex Kft NEW ANTIVIRAL SALTS, pharmaceutical compositions containing AND METHOD FOR PREPARING.
AT398073B (en) * 1988-03-09 1994-09-26 Biorex Kutato Fejlesztoe Kft ANTIVIRAL AND IMMUNOTIMULATING NEW SALTS, AND METHOD FOR THE PRODUCTION AND USE THEREOF
WO1992015277A1 (en) * 1991-03-01 1992-09-17 Bague Jean Claude Cosmetic compositions for make-up and make-up removal
FR2673373A1 (en) * 1991-03-01 1992-09-04 Bague Jean Claude COMPOSITIONS FOR MAKEUP COMPRISING FATTY ACID-BASIC AMINO ACID ASSOCIATIONS FOR FIXING WATER-SOLUBLE COLORING MATERIALS TO THE SKIN.
FR2747309A1 (en) * 1996-04-16 1997-10-17 Morelle Jean Compositions for treating burns and wounds with antimicrobial, anti-free radical and regenerating activity
WO2008006721A1 (en) * 2006-07-14 2008-01-17 Unilever Plc Hair care composition
US8440172B2 (en) 2007-07-09 2013-05-14 Symrise Ag Stable soluble salts of phenylbenzimidazole sulfonic acid at PHS at or below 7.0
US20110240050A1 (en) * 2010-04-01 2011-10-06 L'oreal S.A. Cosmetic compositions containing a fatty acid, arginine, and a co-emulsifier
ITMI20111617A1 (en) * 2011-09-08 2013-03-09 Euro Kemical S R L COSMETIC COMPOSITION BASED ON BABASSU OIL
US20220312803A1 (en) * 2021-03-30 2022-10-06 Apeel Technology, Inc. Edible barrier film composition

Also Published As

Publication number Publication date
FR2587900A1 (en) 1987-04-03
JPS6289646A (en) 1987-04-24
DE3633453A1 (en) 1987-04-02
GB2181647B (en) 1989-10-11
FR2587900B1 (en) 1988-10-07
GB8623076D0 (en) 1986-10-29

Similar Documents

Publication Publication Date Title
GB2181647A (en) Compositions based on lysine and arginine salts
US5520918A (en) Low irritant skin-cosmetic composition for daily topical use, its application and manufacture
JP2003533491A (en) Pharmaceutical and / or cosmetic composition
KR930007911B1 (en) External preparation to prevent coloring
BRPI0115953B1 (en) phosphate derivative complexes
JPS59500129A (en) Sebum-inhibiting cosmetic agent containing long-chain alkanol and antioxidant
MXPA00003830A (en) Coloring agent-containing sunless tanning compositions.
JPS6330884B2 (en)
EP0686027B1 (en) Verwendung eines phenolischen Diterpens zur Herstellung einer Zusammensetzung zur therapeutischen Verwendung auf der Haut
JP2552297B2 (en) Beautiful skin cosmetics
JPH0545569B2 (en)
JP2009507016A (en) Novel skin care composition
KR101072198B1 (en) Cosmetic composition for skin whitening
JP2552298B2 (en) Beautiful skin cosmetics
EP1526849B1 (en) Topical formulations containing ketoprofen stabilised with sulisobenzone
JP2845466B2 (en) Liposomes containing hydroquinone and kojic acid, and pharmaceutical compositions, especially dermatological compositions having skin lightening activity and anti-inflammatory activity, or cosmetics containing liposomes containing kojic acid and hydroquinone The active ingredient composition used for preparing a pharmaceutical composition or a cosmetic composition characterized by comprising:
JP4227332B2 (en) Pyridoxine derivatives, and skin cosmetics and hair cosmetics containing the pyridoxine derivatives
JPH08301745A (en) Skin cosmetic
JPH0780739B2 (en) Antioxidant system and compositions containing same
JP3656197B2 (en) Topical skin preparation
EP1025838B1 (en) A cosmetic composition and a method for reducing the ageing processes of skin
JPH0692833A (en) Skin external agent
JPH072640A (en) External preparation for protecting ultraviolet disorder
JPH06316553A (en) Application of alkanolamine
JP2774063B2 (en) Antioxidant composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930925